Mergers and Acquisitions (M&A): BioMarin (NASDAQ: BMRN) to Acquire Amicus Therapeutics (NASDAQ: FOLD) for $4.8 Billion
San Rafael, California – BioMarin has announced the acquisition of Amicus Therapeutics (https://amicusrx.com/). According to the company announcement BioMarin Pharmaceutical Inc. is a prominent global biotechnology company, established in 1997 and headquartered in San Rafael,…